Richard Straube
Chief Tech/Sci/R&D Officer at SOLIGENIX, INC.
Net worth: 228 $ as of 2024-04-29
Richard Straube active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SOLIGENIX, INC. | Chief Tech/Sci/R&D Officer | 2014-01-05 | - |
Career history of Richard Straube
Former positions of Richard Straube
| Companies | Position | Start | End |
|---|---|---|---|
| STEALTH BIOTHERAPEUTICS CORP | Chief Tech/Sci/R&D Officer | 2008-12-31 | 2014-01-05 |
Critical Biologics Corp.
 Critical Biologics Corp. Medical SpecialtiesHealth Technology Critical Biologics Corp. develops and commercializes diagnostics and therapeutics drugs. The firm focuses in the development of a theranostic platform to screen and treat both acute and chronic patients with low plasma gelsolin levels (hypogelsolinemia) at high risk of life-threatening complications. The company was founded by James W. Fordyce, Terence S. Russell, Shun Lee Po, and Thomas P. Stossel in 2006 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2007-06-13 | 2008-12-31 |
INO Therapeutics LLC
 INO Therapeutics LLC Pharmaceuticals: MajorHealth Technology INO Therapeutics LLC engages in the development of pharmaceutical drugs. The company is headquartered in Hampton, NJ. | Chief Tech/Sci/R&D Officer | 1997-12-31 | 2006-12-31 |
| Ohmeda, Inc. | Corporate Officer/Principal | 1994-12-31 | 1997-01-01 |
| T Cell Sciences, Inc. | Chief Tech/Sci/R&D Officer | 1992-12-31 | 1994-12-31 |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Chief Tech/Sci/R&D Officer | 1987-12-31 | 1992-12-31 |
Inomax LLC (Florida)
 Inomax LLC (Florida) Investment ManagersFinance Inomax LLC is an American venture capital company. | Corporate Officer/Principal | - | - |
| University of California San Diego | Corporate Officer/Principal | 1983-12-31 | - |
Training of Richard Straube
| The University of Chicago | Doctorate Degree |
| London School of Hygiene & Tropical Medicine | Graduate Degree |
Statistics
International
| United States | 11 |
| United Kingdom | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 6 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 4 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SOLIGENIX, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Critical Biologics Corp.
Critical Biologics Corp. Medical SpecialtiesHealth Technology Critical Biologics Corp. develops and commercializes diagnostics and therapeutics drugs. The firm focuses in the development of a theranostic platform to screen and treat both acute and chronic patients with low plasma gelsolin levels (hypogelsolinemia) at high risk of life-threatening complications. The company was founded by James W. Fordyce, Terence S. Russell, Shun Lee Po, and Thomas P. Stossel in 2006 and is headquartered in Cambridge, MA. | Health Technology |
| T Cell Sciences, Inc. | Health Technology |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Inomax LLC (Florida)
Inomax LLC (Florida) Investment ManagersFinance Inomax LLC is an American venture capital company. | Finance |
INO Therapeutics LLC
INO Therapeutics LLC Pharmaceuticals: MajorHealth Technology INO Therapeutics LLC engages in the development of pharmaceutical drugs. The company is headquartered in Hampton, NJ. | Health Technology |
| Ohmeda, Inc. | |
Stealth BioTherapeutics Corp.
 Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Stealth BioTherapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. The company was founded on April 3, 2006 and is headquartered in Needham, MA. | Health Technology |
- Stock Market
- Insiders
- Richard Straube
- Experience
